Citations

Clear

7551 citation(s) found for "Ho, Matthew".

The management of bone loss in revision total knee arthroplasty
Hanssen, Arlen D. , Lewallen, David G. , Sculco, Peter K. , Abdel, Matthew P.

Mayo Clinic

The Bone & Joint Journal | January 5, 2016 | Volume: 98-B | Issue: 1_Supple_A | Pages: 120-124

10.1302/0301-620x.98b1.36345 | PMID 26733657 Get It

The treatment of bone loss in revision total knee arthroplasty has evolved over the past decade. While the management of small to moderate sized defects has demonstrated good results with a variety of traditional techniques (cement and screws, small metal augments, impaction bone grafting or modular stems), the treatment of severe defects continues to be problematic. The use of a structural allograft has declined in recent years due to an increased failure rate with long-term follow-up and with the introduction of highly porous metal augments that emphasise biological metaphyseal fixation. Recently published mid-term results on the use of tantalum cones in patients with severe bone loss has reaffirmed the success of this treatment strategy. Cite this article: Bone Joint J 2016;98-B(1 Suppl A):120–4.
Variability of Brain Death Policies in the United States
Greer, David M. , Wang, Hilary H., Robinson, Jennifer D. , Varelas, Panayiotis N. , Henderson, Galen V., Wijdicks, Eelco F. M. , Greer, David Matthew

Mayo Clinic

JAMA Neurology | December 31, 2015 | Volume: 73 | Issue: 2 | Pages: 213

10.1001/jamaneurol.2015.3943 | PMID 26719912 Get It

Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays
Hoofnagle, Andrew N. , Carr, Steven A. , Liu, Tao , Massoni, Sam A., Thomas, Stefani N. , Townsend, R. Reid , Zimmerman, Lisa J. , Boja, Emily S. , Chen, Jing , Crimmins, Daniel L., Davies, Sherri R. , Hiltke, Tara , Ketchum, Karen A. , Kinsinger, Christopher R. , Mesri, Mehdi , Meyer, Matthew R. , Qian, Weijun , Schoenherr, Regine M., Scott, Mitchell G., Shi, Tujin , Whiteley, Gordon , Wrobel, John A. , Wu, Chaochao, Ackermann, Brad, Barnidge, David R. , Bunk, David M. , Clarke, Nigel J. , Fishman, Jordan B., Grant, Russ P., Kushnir, Mark M. , Lowenthal, Mark S. , Neubert, Hendrik , Patterson, Scott D. , Rockwood, Alan L. , Rogers, John , Eyk, Jennifer E. Van , Wong, Steven, Zhang, Shucha, Chan, Daniel W. , Chen, Xian , Liebler, D.C. , Rodland, Karin , Rodriguez, Henry , Paulovich, Amanda G. , Whiteaker, Jeffrey R. , Kuhn, Eric W. , Gao, Yuqian , Aebersold, Ruedi , Grant, Russell P. , Kusebauch, Ulrike , Moritz, Robert L. , Singh, Ravinder J. , Ellis, Matthew J. , Smith, Richard , Zhang, Zhen , Zhang, Hui , Davies, S. J.

Mayo Clinic

Clinical Chemistry | December 30, 2015 | Volume: 62 | Issue: 1 | Pages: 48-69

10.1373/clinchem.2015.250563 | PMID 26719571 Get It

AbstractBACKGROUNDFor many years, basic and clinical researchers have taken advantage of the analytical sensitivity and specificity afforded by mass spectrometry in the measurement of proteins. Clinical laboratories are now beginning to deploy these work flows as well. For assays that use proteolysis to generate peptides for protein quantification and characterization, synthetic stable isotope–labeled internal standard peptides are of central importance. No general recommendations are currently available surrounding the use of peptides in protein mass spectrometric assays.CONTENTThe Clinical Proteomic Tumor Analysis Consortium of the National Cancer Institute has collaborated with clinical laboratorians, peptide manufacturers, metrologists, representatives of the pharmaceutical industry, and other professionals to develop a consensus set of recommendations for peptide procurement, characterization, storage, and handling, as well as approaches to the interpretation of the data generated by mass spectrometric protein assays. Additionally, the importance of carefully characterized reference materials—in particular, peptide standards for the improved concordance of amino acid analysis methods across the industry—is highlighted. The alignment of practices around the use of peptides and the transparency of sample preparation protocols should allow for the harmonization of peptide and protein quantification in research and clinical care.
Predictors of Whole-Body Insulin Sensitivity Across Ages and Adiposity in Adult Humans
Lalia, Antigoni Z., Dasari, Surendra , Konopka, Adam R. , Distelmaier, Klaus, Port, John D. , Glavin, Maria T., Esponda, Raul Ruiz, Lanza, Ian R. , Johnson, Matthew L. , Robinson, Matthew M. , Glavin, Maria, Nair, K. Sreekumaran , Lanza, Ian R , Port, John D , Konopka, Adam R

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 28, 2015 | Volume: 101 | Issue: 2 | Pages: 626-634

10.1210/jc.2015-2892 | PMID 26709968 Get It

Context:Numerous factors are purported to influence insulin sensitivity including age, adiposity, mitochondrial function, and physical fitness. Univariate associations cannot address the complexity of insulin resistance or the interrelationship among potential determinants.Objective:The objective of the study was to identify significant independent predictors of insulin sensitivity across a range of age and adiposity in humans.Design, Setting, and Participants:Peripheral and hepatic insulin sensitivity were measured by two stage hyperinsulinemic-euglycemic clamps in 116 men and women (aged 19–78 y). Insulin-stimulated glucose disposal, the suppression of endogenous glucose production during hyperinsulinemia, and homeostatic model assessment of insulin resistance were tested for associations with 11 potential predictors. Abdominal subcutaneous fat, visceral fat (AFVISC), intrahepatic lipid, and intramyocellular lipid (IMCL) were quantified by magnetic resonance imaging and spectroscopy. Skeletal muscle mitochondrial respiratory capacity (state 3), coupling efficiency, and reactive oxygen species production were evaluated from muscle biopsies. Aerobic fitness was measured from whole-body maximum oxygen uptake (VO2 peak), and metabolic flexibility was determined using indirect calorimetry.Results:Multiple regression analysis revealed that AFVISC (P < .0001) and intrahepatic lipid (P = .002) were independent negative predictors of peripheral insulin sensitivity, whereas VO2 peak (P = .0007) and IMCL (P = .023) were positive predictors. Mitochondrial capacity and efficiency were not independent determinants of peripheral insulin sensitivity. The suppression of endogenous glucose production during hyperinsulinemia model of hepatic insulin sensitivity revealed percentage fat (P < .0001) and AFVISC (P = .001) as significant negative predictors. Modeling homeostatic model assessment of insulin resistance identified AFVISC (P < .0001), VO2 peak (P = .001), and IMCL (P = .01) as independent predictors.Conclusion:The reduction in insulin sensitivity observed with aging is driven primarily by age-related changes in the content and distribution of adipose tissue and is independent of muscle mitochondrial function or chronological age.
Open Anatomic Reconstruction of the Medial Collateral Ligament and Posteromedial Corner
Prince, Matthew, Blackman, Andrew J. , King, Alexander H. , Levy, Bruce A. , Prince, Matthew R, Stuart, Michael J.

Mayo Clinic

Arthroscopy Techniques | December 28, 2015 | Volume: 4 | Issue: 6 | Pages: No page available

10.1016/j.eats.2015.08.013 | PMID 27284529 Get It

Abstract Injuries to the medial collateral ligament (MCL) and posteromedial corner can occur in isolation or in the setting of multiligamentous knee injuries. Reconstruction of the MCL and posteromedial corner is indicated in the setting of a multiligamentous knee injury. Isolated cases failing nonoperative treatment may also undergo surgical treatment. Our preferred technique for anatomic medial‐sided knee reconstruction is an open anatomic MCL reconstruction using an Achilles tendon allograft along with direct repair of all associated medial and posteromedial structures. Technique Video video See video under supplementary data.
Pre‐transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation
Kelm, Diana J. , Bonnes, Sara L. , Jensen, Michael D. , Eiken, Patrick W. , Hathcock, Matthew , Kremers, Walter K. , Kennedy, Cassie C. , Hathcock, Matthew A, Kennedy, Cassie C , Kremers, Walter K

Mayo Clinic

Clinical Transplantation | December 24, 2015 | Volume: 30 | Issue: 3 | Pages: 247-255

10.1111/ctr.12683 | PMID 26701203 Get It

Abstract Background Frailty in non‐transplant populations increases morbidity and mortality. Muscle wasting is an important frailty characteristic. Low body mass index is used to measure wasting, but can over‐ or underestimate muscle mass. Computed tomography ( CT ) software can directly measure muscle mass. It is unknown if muscle wasting is important in lung transplantation. Aim and Methods The aim of this single‐center, retrospective cohort study was to determine whether pre‐transplant low muscle mass (as measured by CT using Slice‐O‐matic software at L2–L3 interspace) was associated with post‐transplantation mortality, hospital and intensive care unit length of stay ( LOS ), duration of mechanical ventilation, or primary graft dysfunction. Lung transplant recipients from 2000 to 2012 with a CT scan less than six months prior to transplant were included. Univariate, multivariate, and Kaplan–Meier analyses were conducted. Results Thirty‐six patients were included. Those with low muscle index (lower 25th percentile) had a worse survival (hazard ratio = 3.83; 95% confidence interval 1.42–10.3; p = 0.007) and longer hospital LOS by an estimated 7.2 d (p = 0.01) when adjusted for age and sex as compared to those with higher muscle index. Conclusion Low muscle index at lung transplantation is associated with worse survival and increased hospital LOS .
Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup
Moschini, Marco , Sharma, Vidit , Zattoni, Fabio , Boorjian, Stephen A. , Frank, Igor, Gettman, Matthew T., Thompson, R. Houston, Tollefson, Matthew K. , Kwon, Eugene D., Karnes, R. Jeffrey , Moschini, Marco , Zattoni, Fabio

Mayo Clinic

Journal of Urology | December 23, 2015 | Volume: 195 | Issue: 6 | Pages: 1773-1778

10.1016/j.juro.2015.12.074 | PMID 26723866 Get It

Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy—What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?
Toussi, Amir , Stewart‐Merrill, Suzanne B., Boorjian, Stephen A. , Psutka, Sarah P. , Thompson, R. Houston, Frank, Igor, Tollefson, Matthew K. , Gettman, Matthew T., Carlson, Rachel E. , Rangel, Laureano J. , Karnes, R. Jeffrey , Psutka, Sarah P

Mayo Clinic

Journal of Urology | December 23, 2015 | Volume: 195 | Issue: 6 | Pages: 1754-1759

10.1016/j.juro.2015.12.075 | PMID 26721226 Get It

A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1
Lu, Kang , Grande, Joseph P. , Hillestad, Matthew L. , Croatt, Anthony J., Barry, Michael A. , Katušić, Zvonimir S. , Nath, Karl A. , Kang, Lu, Barry, Michael A

Mayo Clinic

American Journal of Physiology-Renal Physiology | December 16, 2015 | Volume: 310 | Issue: 6 | Pages: F466-F476

10.1152/ajprenal.00288.2015 | PMID 26672617 Get It

The arteriovenous fistula (AVF) is the preferred hemodialysis vascular access, but it is complicated by high failure rates and attendant morbidity. This study provides the first description of a murine AVF model that recapitulates two salient features of hemodialysis AVFs, namely, anastomosis of end-vein to side-artery to create the AVF and the presence of chronic kidney disease (CKD). CKD reduced AVF blood flow, observed as early as 3 days after AVF creation, and increased neointimal hyperplasia, venous wall thickness, thrombus formation, and vasculopathic gene expression in the AVF. These adverse effects of CKD could not be ascribed to preexisting alterations in blood pressure or vascular reactivity in this CKD model. In addition to vasculopathic genes, CKD induced potentially vasoprotective genes in the AVF such as heme oxygenase-1 (HO-1) and HO-2. To determine whether prior HO-1 upregulation may protect in this model, we upregulated HO-1 by adeno-associated viral gene delivery, achieving marked venous induction of the HO-1 protein and HO activity. Such HO-1 upregulation improved AVF blood flow and decreased venous wall thickness in the AVF. Finally, we demonstrate that the administration of carbon monoxide, a product of HO, acutely increased AVF blood flow. This study thus demonstrates: 1) the feasibility of a clinically relevant murine AVF model created in the presence of CKD and involving an end-vein to side-artery anastomosis; 2) the exacerbatory effect of CKD on clinically relevant features of this model; and 3) the beneficial effects in this model conferred by HO-1 upregulation by adeno-associated viral gene delivery.